Affiliation:
1. Department of Microbiology, Immunology and Pathology Colorado State University Fort Collins Colorado USA
2. Analytical Resources Core‐Bioanalysis and Omics Colorado State University Fort Collins Colorado USA
Abstract
AbstractThe ratio of κ light chains to λ light chains (κ:λ) in serum is used as a biomarker of immunoglobulin secreting neoplasia in humans but has not been evaluated in dogs. A mass‐spectrometry based method for determining the canine serum κ:λ was developed and used to evaluate samples from control dogs, dogs with an infectious aetiology, dogs with secretory plasma cell tumours (sPCT) and dogs with non‐secretory B cell neoplasia. A human‐targeted immunoturbidometric κ:λ assay and immunofixation using antisera targeting human κ light chain or λ light chain was also performed on all samples. Using whole serum samples, the MS‐based κ:λ method identified 5 sPCT as κ‐predominant (mean κ:λ = 3.307) and 5 sPCT as λ‐predominant (mean κ:λ = 0.023) and documented differences between these groups and all other groups (p < 0.05 for all). The infectious aetiology group had a lower mean κ:λ ratio (mean κ:λ = 0.069) than control samples (mean κ:λ = 0.103, p = 0.035). Similar results were obtained when samples were enriched for proteins between 10 and 50 kDa using size exclusion chromatography, except for the statistical difference between the control and infectious aetiology group. All λ‐predominant cases had only anti‐human λ light chain labelling by immunofixation. Three κ‐predominant cases had only anti‐human κ‐light chain labelling and the remaining two cases did not label with either antisera by immunofixation. The immunoturbidometric method had high analytical CV% (λ light chain CV = 13%, κ light chain CV = 50%), was unable to measure light chains in 20.5% of samples and did not distinguish groups. The data suggests that the human‐targeted immunoturbidometric method would not be diagnostically useful and that the MS‐derived serum κ:λ may be a useful biomarker of canine immunoglobulin secretory neoplasia which may have the ability to distinguish neoplasia from infectious causes of immunoglobulin secretion.